MikeTrendsTrends right now

search

insulin

Trends

  1. 1
    Pancreatic Cells One Genetic Tweak From Treating Diabetes▼Some Pancreatic Cells Are Just One Genetic Tweak Away From Treating Diabetes https:// fed.brid.gy/r/https://www.wire d.cMmastodonScience312 min ago

    New research suggests some pancreatic cells could be converted into insulin-producing cells with a single genetic modification, offering a promising avenue for diabetes treatment. The findings, reported by Wired, point to the potential of reprogramming existing cells to restore insulin function in patients. Scientists and health watchers are sharing the story as a possible step toward new therapies for the disease.

  2. 2
    The End of Insulin Injections? Scientists Push Needle-Free Medicine▼The End of Insulin Injections? How Scientists Are Making Medicine Needle-Free✉newsHealthMedicine3 min ago

    Scientists are developing needle-free alternatives to insulin injections, a shift that could transform daily treatment for millions of people with diabetes. Reported by National Geographic, the work covers new delivery methods being explored to replace traditional syringes. The topic is drawing attention among patients and medical observers who see it as a potential turning point in how routine medicines are administered.

  3. 3
    Israeli startup wins FDA clearance for injection-based diabetes app▼Israeli startup develops injection-based diabetes app, receives FDA clearance✉newsBusinessStartups30 min ago

    An Israeli startup has received US Food and Drug Administration clearance for an app designed to support people managing diabetes with injections. The digital tool is aimed at helping patients track and handle their insulin treatment more effectively. The clearance marks a regulatory milestone for the young company, and coverage in Israeli media highlights it as another example of the country's health-tech sector gaining traction abroad.

  4. 4
    FDA approves Onswik, a once-weekly insulin for type 2 diabetes●The FDA approved Onswik, a once-weekly insulin for type 2 diabetes, but not for type 1. What the trials showed and the sMmastodonHealthMedicine29 h ago

    The FDA has approved Onswik, a once-weekly insulin intended for adults with type 2 diabetes. It was not approved for type 1 diabetes. Coverage highlights what the clinical trials showed about effectiveness and the side effects patients should know about. The approval is drawing attention as a potential convenience shift for diabetes management, reducing injections from daily to weekly.